Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Epigenome-Wide Association Study (EWAS) of Blood Lipids in Healthy Population from STANISLAS Family Study (SFS)

Xie T., Gorenjak V., G Stathopoulou M., Dadé S., Marouli E., Masson C.

Laboratory Study on Hip, published in Int J Mol Sci (2019) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Int J Mol Sci (2019)
Reported sample size
—
Source database
Europe PMC
PMID
30813608
PMCID
PMC6429274
DOI
10.3390/ijms20051014
Citations
12

Abstract (original English)

Epigenome-Wide Association Studies (EWAS) are furthering our knowledge of epigenetic modifications involved in the regulation of lipids' metabolism. Furthermore, epigenetic patterns associated with lipid levels may play an important role in predicting the occurrence of cardiovascular events. To further investigate the relationship between methylation status and lipids, we performed an EWAS in 211 individuals from the STANISLAS Family study (SFS). Methylation at two CpG sites ( PRKAG2 ; p = 1.39 × 10 -8 ; KREMEN2 ; p = 5.75 × 10 -9 ) were significantly associated with lipidomic profiles. Replication was sought in adipose tissue where one probe, cg08897188, was found to be nominally significant ( KREMEN2 ; p = 0.0196). These results could provide new insight in the mechanisms underlying cardiovascular diseases and contribute to new therapeutic interventions.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueHumansLipidsReproducibility of ResultsFamilyComputational BiologyDNA MethylationEpigenesis, GeneticCpG IslandsPromoter Regions, Genetic

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research